Valuation Astellas Pharma Inc. Deutsche Boerse AG

Stocks

YPH

JP3942400007

Pharmaceuticals

Real-time Estimate Tradegate 12:07:05 2026-09-10 EDT			5-day change	1st Jan Change
12.15 ^EUR	+0.41%		-8.33%	+8.72%

09-01	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
09-01	White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies	MT

Company Valuation: Astellas Pharma Inc.

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	3,993,042	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-11.51%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	3,933,863	3,512,387	3,137,100
Change	-	-6.22%	-13.1%	23.8%	48.4%	-17.99%	-10.71%	-10.68%
P/E	28.5x	34.7x	173x	51x	15.5x	10.7x	11.4x	14.8x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	1.95x	1.78x	1.69x
PEG	-	-1.8x	-2.1x	0x	0x	0.4x	-2.02x	-0.6x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.71x	1.85x	2.08x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.69x	1.63x	1.64x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.31x	5.19x	5.48x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.12x	7.77x	8.53x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	8.68x	6.68x	6.53x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	11.5%	15%	15.3%
Dividend per Share ²	50	60	70	74	78	80.31	83.23	85.46
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.61%	3.74%	3.84%
EPS ²	67.08	54.24	9.51	28.35	162.8	207.2	195.5	150.8
Distribution rate	74.5%	111%	736%	261%	47.9%	38.8%	42.6%	56.7%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,328,915	2,155,168	1,915,459
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	740,737	677,049	572,836
EBIT ¹	155,686	133,029	25,518	41,039	382,633	484,184	452,041	367,633
Net income ¹	124,086	98,714	17,045	50,747	291,535	355,791	332,521	252,140
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-59,179	-480,654	-855,942
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,227.00	2,227.00	2,227.00
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,793,014	-	-
Announcement Date	4/27/22	4/27/23	4/25/24	4/25/25	4/27/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32x	11.63x	23.59x	0.62%	1,002B
JOHNSON & JOHNSON	28.37x	6.53x	17.91x	2.01%	644B
ABBVIE INC.	32.13x	7.46x	15.49x	2.73%	443B
ROCHE HOLDING AG	18.9x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	19.46x	5.11x	12.69x	3.2%	262B
ASTRAZENECA PLC	20.29x	4.17x	11.93x	2.12%	245B
AMGEN INC.	24.75x	6.5x	11.57x	2.58%	212B
NOVO NORDISK A/S	12.86x	4.67x	9.75x	3.91%	199B
GILEAD SCIENCES, INC.	-44.5x	6.43x	25.11x	2.26%	181B
Average	16.03x	6.35x	15.50x	2.48%	392.19B
Weighted average by Cap.	22.91x	7.53x	17.31x	2.04%